In today’s ACT Brief, we examine the growing challenges of sourcing comparator drugs across the EU, highlight a new AI-driven ...

Securing comparator drugs in the EU is a complex process shaped by availability constraints, regulatory expectations, and competitive market behavior. But if we have the right planning, strong ...

IM1240 demonstrated improved safety in a toxicology study at doses up to 300-fold higher than a non-capped comparator ...

Using a single microcontroller port to drive a multi-digit LED display to help engineers with those last-minute design ...

On track to define optimal dosing interval and advance manufacturing scale up of REYOBIQ for pivotal trial readiness in late ...

Fig 1. The traditional window comparator with a single op amp has interactions between the output and the reference voltage that creates uncertainty in its hysteresis window width. Fig 2. Adding a ...

Laboratories are no longer peripheral. They are central to modern clinical development - enabling earlier decision-making, ...

A Type B meeting between the FDA and Plus Therapeutics offered clarity and direction for the next steps in development of ...

Nigeria’s tax performance has long been an anomaly among peer economies. With a tax-to-GDP ratio hovering well below 15 ...

Immuneering Corporation stays a Strong Buy: pancreatic cancer combo shows 64% 12‑mo OS, strong safety, and clear catalysts ...

Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, today announced Dyno-yp2, a novel adeno-associated ...